Fundz

In Carda Therapeutics, Inc. reported raising $35.3 Million in an initial SEC Form D filing, from an offering of $42.1 Million

PRIVATENov 08, 2019$35.3M of $42.1M raised

Amount Raised

$35.3 Million

$35.3 Million sold, per SEC Form D (first sale Nov 8, 2019)

Round Type

Venture

NewarkHealthcare

Quick answer

InCarda Therapeutics, Inc. raised $35.3 Million in a funding round, dated November 8, 2019. InCarda Therapeutics, Inc. is based in Newark, California, United States.

How much did InCarda Therapeutics, Inc. raise?
InCarda Therapeutics, Inc. raised $35.3 Million in a funding round on November 8, 2019.
What does InCarda Therapeutics, Inc. do?
InCarda Therapeutics is a clinical stage drug delivery company pioneering a novel approach of treating cardiovascular diseases and conditions by the inhalation route.
Where is InCarda Therapeutics, Inc. based and how big is it?
InCarda Therapeutics, Inc. is based in Newark, California, United States.
Who are the decision-makers at InCarda Therapeutics, Inc?
Fundz holds 1 contact at InCarda Therapeutics, Inc. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare around the same time

Companies in the same sectors as InCarda Therapeutics, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • NeuroTronik, Inc. raised $119K (Seed) on December 23, 2019.
  • Specialists On Call, Inc. raised $13M on December 23, 2019.
  • Kinnate Biopharma raised $74M on December 23, 2019.
  • Site Saver, Inc. raised $576K (Seed) on December 23, 2019.
  • TMRW Life Sciences raised $29M on December 23, 2019.
  • Specialists On Call, Inc. raised $2M (Seed) on December 23, 2019.

Who to call at InCarda Therapeutics, Inc., and when

A new round usually means InCarda Therapeutics, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day InCarda Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at InCarda Therapeutics, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at InCarda Therapeutics, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

InCarda Therapeutics, Inc.

Location

39899 BALENTINE DRIVE, SUITE 185

Newark, California, United States

About

InCarda Therapeutics is a clinical stage drug delivery company pioneering a novel approach of treating cardiovascular diseases and conditions by the inhalation route. The lead product under development is an inhaled therapy to treat a common atrial arrhythmia, paroxysmal atrial fibrillation (PAF).

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment InCarda Therapeutics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts12 people are listed at InCarda Therapeutics, Inc.. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for InCarda Therapeutics, Inc.'s next move

See what Strategic adds

InCarda Therapeutics, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.